DENTSPLY SIRONA (NASDAQ:XRAY) Stock Gets Downgrade from Zacks Research

DENTSPLY SIRONA (NASDAQ:XRAY) was downgraded by equities researchers at Zacks Research from a “hold” rating to a “strong sell” rating in a research report issued to clients and investors on Monday, Zacks reports.

Several other equities analysts have also recently weighed in on XRAY. Mizuho cut their price objective on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a report on Thursday, October 22nd. Weiss Ratings reissued a “sell (e+)” rating on shares of DENTSPLY SIRONA in a research note on Friday, October 30th. Barrington Research dropped their target price on shares of DENTSPLY SIRONA from $15.00 to $13.00 and set an “outperform” rating on the stock in a report on Monday, October 26th. BMO Capital Markets dropped their target price on shares of DENTSPLY SIRONA from $13.00 to $10.00 and set a “market perform” rating on the stock in a report on Thursday, September 17th. Finally, Barclays lifted their price target on shares of DENTSPLY SIRONA from $9.00 to $11.00 and gave the company an “underweight” rating in a research note on Monday, August 24th. Three research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have issued a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Reduce” and a consensus price target of $12.42.

DENTSPLY SIRONA Stock Performance

Shares of DENTSPLY SIRONA stock opened at $9.70 on Monday. The company has a market capitalization of $1.92 billion, a PE ratio of -15.64, a PEG ratio of 1.36 and a beta of 0.87. DENTSPLY SIRONA has a 12 month low of $8.14 and a 12 month high of $14.76. The company has a current ratio of 1.63, a quick ratio of 1.04 and a debt-to-equity ratio of 1.47. The stock’s fifty day simple moving average is $9.54 and its 200 day simple moving average is $11.25.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Thursday, November 5th. The medical instruments supplier reported $0.29 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.31 by ($0.02). DENTSPLY SIRONA had a negative net margin of 3.38% and a positive return on equity of 20.21%. The business had revenue of $836.00 million during the quarter, compared to analyst estimates of $861.68 million. During the same period in the previous year, the firm posted $0.37 earnings per share. The firm’s revenue was down 7.5% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2026 guidance at 1.200-1.300 EPS. On average, research analysts predict that DENTSPLY SIRONA will post 1.24 EPS for the current year.

Institutional Trading of DENTSPLY SIRONA

A number of institutional investors have recently made changes to their positions in the business. BlackRock Inc. acquired a new position in DENTSPLY SIRONA during the second quarter worth $283,405,000. Southpoint Capital Advisors LP acquired a new stake in DENTSPLY SIRONA in the 1st quarter valued at $116,000,000. Edmond DE Rothschild Holding S.A. acquired a new stake in DENTSPLY SIRONA in the 2nd quarter valued at $47,780,000. Paradigm Capital Management Inc. NY acquired a new stake in DENTSPLY SIRONA in the 2nd quarter valued at $39,775,000. Finally, Bank of America Corp DE bought a new stake in DENTSPLY SIRONA during the 2nd quarter worth about $31,001,000. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc. develops, manufactures and markets products and technologies for dental professionals. Its portfolio includes dental equipment and imaging systems, digital dentistry and CAD/CAM solutions, dental implants, endodontic and restorative products, and supplies used in preventive care. The company serves dental practices, laboratories and other customers around the world. Its products support a range of clinical activities, including diagnosis, treatment planning, restorative dentistry and oral hygiene.